Business OpportunityUpdated on 27 November 2025
PRISMA-AI-enabled Multimodal Decision-Support Integrating Clinical Notes and Biomarkers for Early Risk Stratification in Chronic Diseases
CEO at SYNOESIS THERAPEUTICS LTD
Heraklion, Greece
About
We have developed a TRL6 clinical-note NLP engine validated on large, real-world EHR datasets (ICU/ED; multilingual Greek/English), demonstrating consistent applicability across chronic-disease and multimorbidity contexts. Its prognostic risk outputs enable earlier and more effective management of chronic disease trajectories, with strong results in CKD and clear potential for neurological multimorbidity. Through PRECISEU, we aim to advance this NLP engine to TRL8 via deployment in multiple clinical regions and integration into routine workflows. Additionally, we have observed that adding biological biomarkers improves predictive performance. During the project, we will also integrate biomarker data from CKD and neurological patient cohorts to build a unified multimodal clinical decision-support companion. We seek hospitals with structured EHR notes (internal medicine, nephrology, neurology) and partners experienced in EHR integration to support deployment and validation of the platform in real clinical workflows.
Stage
- TRL 6
Topic
- Bioinformatics
- Endocrine/nutritional/metabolic diseases
- Mental and behavioural disorders / psychiatry /psychology
- Diseases of the nervous system / neurology
- Proteomics
- Other
Sector
- Health data
- AI
- Diagnostics
Type
- Research collaboration
- Co-development
- Clinical validation
- Consortium partners
Organisation
Similar opportunities
Business Opportunity
AI-powered Healthcare with therapeutic red blood cells
- AI
- TRL 6
- ATMPs
- Health data
- Diagnostics
- Rare diseases
- Rare diseases
- Co-development
- Clinical validation
- Regenerative medicine
- Endocrine/nutritional/metabolic diseases
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Denis Demarais
Founder and CEO at Rius Medical
Waldachtal, Germany
Business Opportunity
- TRL 6
- TRL 7
- TRL 8
- Health data
- Rare diseases
- Research collaboration
- Congenital or chromosomal abnormalities
- Diseases of the blood and immune disorders
Jacques Riviere
Pediatric immunologist, researcher at Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain
Business Opportunity
DIGITAL HEALTH CARE ASSISTANCE CHRONIC DISEASES
- TRL 7
- Respiratory
- Health data
- Rare diseases
- Rare diseases
- Co-development
- Regulatory expert
- Diseases of the ear
- Consortium partners
- External causes of morbidity, mortality
- Endocrine/nutritional/metabolic diseases
- Musculoskeletal system, connective tissue
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Heike Heimann
Company Management WIN5 at WIN5
Stuttgart, Germany